AT291435B - Verfahren zur Herstellung neuer Derivate der 7-Aminocephalosporansäure - Google Patents

Verfahren zur Herstellung neuer Derivate der 7-Aminocephalosporansäure

Info

Publication number
AT291435B
AT291435B AT1268368A AT1268368A AT291435B AT 291435 B AT291435 B AT 291435B AT 1268368 A AT1268368 A AT 1268368A AT 1268368 A AT1268368 A AT 1268368A AT 291435 B AT291435 B AT 291435B
Authority
AT
Austria
Prior art keywords
preparation
new derivatives
aminocephalosporanic acid
aminocephalosporanic
acid
Prior art date
Application number
AT1268368A
Other languages
English (en)
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Application granted granted Critical
Publication of AT291435B publication Critical patent/AT291435B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT1268368A 1968-01-02 1968-12-30 Verfahren zur Herstellung neuer Derivate der 7-Aminocephalosporansäure AT291435B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH268A CH497462A (de) 1968-01-02 1968-01-02 Verfahren zur Herstellung neuer Derivate der 7-Aminocephalosporansäure

Publications (1)

Publication Number Publication Date
AT291435B true AT291435B (de) 1971-07-12

Family

ID=4177186

Family Applications (2)

Application Number Title Priority Date Filing Date
AT1268368A AT291435B (de) 1968-01-02 1968-12-30 Verfahren zur Herstellung neuer Derivate der 7-Aminocephalosporansäure
AT847370A AT295038B (de) 1968-01-02 1968-12-30 Verfahren zur Herstellung von neuen Derivaten der 7-Aminocephalosporansäure

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT847370A AT295038B (de) 1968-01-02 1968-12-30 Verfahren zur Herstellung von neuen Derivaten der 7-Aminocephalosporansäure

Country Status (3)

Country Link
AT (2) AT291435B (de)
CH (2) CH498152A (de)
SU (2) SU419039A3 (de)

Also Published As

Publication number Publication date
SU419039A3 (de) 1974-03-05
AT295038B (de) 1971-12-27
CH497462A (de) 1970-10-15
CH498152A (de) 1970-10-31
SU419040A3 (ru) 1974-03-05

Similar Documents

Publication Publication Date Title
AT321457B (de) Verfahren zur Herstellung neuer 7-Aminocephalosporansäurederivate
CH480365A (de) Verfahren zur Herstellung neuer Derivate der 7-Aminocephalosporansäure
AT306015B (de) Verfahren zur Herstellung neuer Derivate der Phenylessigsäure
AT297018B (de) Verfahren zur Herstellung neuer Derivate der Thiocarbamidsäure
AT306714B (de) Verfahren zur Herstellung neuer Nitroimidazolderivate
CH476021A (de) Verfahren zur Herstellung neuer Derivate der 7-Amino-cephalosporansäure
CH522677A (de) Verfahren zur Herstellung neuer Derivate der 7-Aminocephalosporansäure
AT303000B (de) Verfahren zur Herstellung neuer Triazenderivate
CH501608A (de) Verfahren zur Herstellung neuer Derivate des Oestratriens
CH498120A (de) Verfahren zur Herstellung neuer Indenopyridinderivate
CH513119A (de) Verfahren zur Herstellung neuer Halogencolchicinderivate
CH515887A (de) Verfahren zur Herstellung der 4-Aminomethylcuban-1-carbonsäure
AT301024B (de) Verfahren zur Herstellung neuer Derivate der 7-Aminocephalosporansäure
AT249861B (de) Verfahren zur Herstellung neuer Derivate der 7-Aminocephalosporansäure
CH537947A (de) Verfahren zur Herstellung neuer Cephalosporansäurederivate
AT287703B (de) Verfahren zur Herstellung neuer Imidazolderivate
CH533633A (de) Verfahren zur Herstellung neuer Phenanthrotriazolylderivate
AT297933B (de) Verfahren zur Herstellung neuer Derivate der 7-Aminocephalosporansäure
AT297924B (de) Verfahren zur Herstellung neuer Derivate der 7-Aminocephalosporansäure
AT291435B (de) Verfahren zur Herstellung neuer Derivate der 7-Aminocephalosporansäure
AT293614B (de) Verfahren zur Herstellung neuer Cephalosporinderivate
AT293635B (de) Verfahren zur Herstellung neuer 18-Methyl-5α-H-androstanderivate
CH476760A (de) Verfahren zur Herstellung neuer Derivate der 7-Amino-cephalosporansäure
AT261110B (de) Verfahren zur Herstellung neuer Derivate der 7 Aminocephalosporansäure
AT298468B (de) Verfahren zur Herstellung neuer Arylketenderivate

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee